Coronavirus: ‘Witches’ advocate challenges Apostle Suleiman to heal a COVID-19 patient and get $1k reward

'Witches' advocate challenges Apostle Suleiman to heal a COVID-19 patient-Medratimes

Leo Igwe, the Director of Advocacy for Alleged Witches (AFAW), has challenged Apostle Johnson Suleman to miraculously heal a Coronavirus patient or an HIV patient and get $1,000.

AFAW had on Sunday attacked Suleman for demanding that the government should allow pastors into isolation centers to pray and heal COVID-19 patients.

In reaction to Apostle Suleman’s demands, Leo Igwe, who is the founder of the Nigerian Humanist Movement and also the director of the Advocacy for Alleged Witches, wrote an open letter to Apostle Suleiman, challenging him to prove his spiritual powers and get rewarded for it.

Leo Igwe wrote in the letter: “I am challenging the founder of Omega Ministries, Apostle Suleman, to demonstrate his so-called gift of healing under agreed medical and scientific conditions. I ask Suleman to heal a person with a confirmed case of COVID-19 and get a thousand US dollars. This challenge has become necessary because Apostle Suleman has in a recent video urged the government of Nigeria to allow him and other pastors with the gift of healing into the isolation centers so that they could pray and heal those who have been infected by the virus.

“This request should not go unattended. Suleman specifically said that the gifted pastors could heal 18 out of 20 COVID-19 patients. This is a reasonable number. Isn’t it? And in a recent tweet, Apostle Suleman affirmed that (his) God was bigger than the Coronavirus. This challenge is for Suleman to heal, not two or three persons, not 10 or 15 patients but one person with a viral infection.”

Mr Igwe further added that various religious leaders are always claiming they performed miracles to heal numerous diseases “through faith and prayers”. He said now is the time to prove that they are effective.

READ ALSO: COVID-19 Patients Recovering Fast After Getting Experimental Drug, Remdesivir – REPORT


Be the first to comment

Leave a Reply

Your email address will not be published.